Normal view MARC view ISBD view

Abiraterone or Docetaxel Plus Androgen Deprivation in Hormone-Sensitive Prostate Cancer: More Questions Than Answers.

Aggarwal, Rahul

Abiraterone or Docetaxel Plus Androgen Deprivation in Hormone-Sensitive Prostate Cancer: More Questions Than Answers. [electronic resource] - European urology 06 2018 - 845-846 p. digital

Publication Type: Editorial; Comment

ISSN: 1873-7560

Standard No.: 10.1016/j.eururo.2017.10.028 doi

Subjects--Topical Terms:
Abiraterone Acetate
Androgen Antagonists
Androstenes
Antineoplastic Combined Chemotherapy Protocols
Docetaxel
Humans
Male
Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant
Taxoids

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)